fda warning letters glp-1 compounders october 2025 Beyond the Headlines: to FDA ramps up its pushback

Liraglutide (Victoza and Saxenda) Liraglutide, sold under the brand names Victoza and Saxenda, treats type 2 diabetes and obesity

It helps identify patterns over time, providing valuable insights into their body's response to GLP-1 medication

[6], [7] Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is the most prevalent chronic liver disorder worldwide, with an increasing incidence driven by the global rise in obesity and metabolic syndrome

It takes some getting used to because it can cause some nausea or diarrhea when you first start taking it. You may be able to avoid this by starting with a low dose, and building up gradually, she adds